Abstract
Radiation therapy is an established modality for the treatment of malignant gliomas. Several reports have shown the advantage of additional radiation in combination with gene therapy. In this study, we investigated the ability of radiation therapy to enhance 5-fluorocytosine (5-FC)/cytosine deaminase (CD) plus uracil phosphoribosyltransferase (UPRT) gene therapy in malignant gliomas. In vitro study suggested evidence of a significant cytotoxic interaction between radiation therapy and 5-FC/CD+UPRT gene therapy for glioma cells. In vivo experiments demonstrated that the combination of gene therapy and radiation possessed superior antitumor effect in comparison to single therapy. However, the adverse effects of radiation therapy in combination with the gene therapy were observed with respect to normal brain. This combination therapy may be feasible for the treatment of gliomas, although the radiation dose and area should be reduced in order to prevent side effects.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ichikawa T, Tamiya T, Adachi Y et al. In vivo efficacy and toxicity of 5-fluorocytosine/cytosine deaminase gene therapy for malignant gliomas mediated by adenovirus Cancer Gene Ther 2000 7: 74–82
Adachi Y, Tamiya T, Ichikawa T et al. Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine Hum Gene Ther 2000 11: 77–89
Tamiya T, Ono Y, Wei MX et al. Escherichia coli gpt gene sensitizes rat glioma cells to killing by 6-thioxanthine or 6-thioguanine Cancer Gene Ther 1996 3: 155–162
Nishiyama T, Kawamura Y, Kawamoto K et al. Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules Cancer Res 1985 45: 1753–1761
Ohwada A, Hirshowtiz EA, Cristal RG . Regional delivery of an adenovirus vector containing the Escherichia coli cytosine deaminase gene to provide local activation of 5-fluorocytosine to suppress the growth of colon carcinoma metastatic to liver Hum Gene Ther 1996 7: 1567–1576
Hirshowitz EA, Ohwada A, Pascal WR et al. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induced chemosensitivity to 5-fluorocytosine Hum Gene Ther 1995 6: 1055–1063
Lan K-H, Kanai F, Shiratori Y et al. In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma Cancer Res 1997 57: 4279–4284
Kanai F, Lan K-H, Shiratori Y et al. In vivo gene therapy for alfa-fetoprotein–producing hepatocellular carcinoma by adenovirus-mediated transfer of cytosine deaminase gene Cancer Res 1997 57: 461–465
Dong Y, Wen P, Manome Y et al. In vivo replication-deficient adenovirus vector–mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine Hum Gene Ther 1996 7: 713–720
Kanai F, Kawakami T, Hamada H et al. Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyltransferase gene sensitizes cancer cells to low concentration of 5-fluorouracil Cancer Res 1998 58: 1946–1951
Tiraby M, Cazaux C, Baron M et al. Concomitant expression of E. coli cytosine deaminase and uracil phosphoribosyltransferase improves the cytotoxicity of 5-fluorocytosine FEMS Microbiol Lett 1998 167: 41–49
Broaddus WC, Liu Y, Steele LL et al. Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction J Neurosurg 1999 91: 997–1004
Badie B, Goh CS, Klaver J et al. Combined radiation and p53 gene therapy of malignant glioma cells Cancer Gene Ther 1999 6: 155–162
Valerie K, Brust D, Farnworth J et al. Improved radiosensitization of rat glioma cells with adenovirus-expressed mutant herpes simplex virus-thymidine kinase in combination with acyclovir Cancer Gene Ther 2000 7: 879–884
Marples B, Scott SD, Hendry JH et al. Development of synthetic promoters for radiation-mediated gene therapy Gene Ther 2000 7: 511–517
Rogulski KR, Kim JH, Kim SH et al. Glioma cells transduced with an E. coli CD/HSV-1 TK fusion gene exhibit enhanced metabolic suicide and radiosensitivity Hum Gene Ther 1997 8: 73–85
Kim SH, Kim JH, Kolozsvary A et al. Preferential radiosensitization of 9 L glioma cells transduced with HSV-tk gene by acyclovir J Neuro-Oncol 1997 33: 189–194
Kim JH, Kim SH, Kolozsvary A et al. Selective enhancement of radiation response of herpes simplex virus thymidine kinase transduced 9 L gliosarcoma cells in vitro and in vivo by antiviral agents Int J Radiat Oncol Biol Phys 1995 33: 861–868
Freytag SO, Rogulski KR, Paielli DL et al. A novel three-pronged approach to kill cancer cells selectively: concomitant viral, double suicide gene, and radiotherapy Hum Gene Ther 1998 9: 1323–1333
Pederson LC, Bushsbaum DJ, Vickers SM et al. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo Cancer Res 1997 57: 4325–4332
Khil MS, Kim JH, Mullen CA et al. Radiosensitization by 5-fluorocytosine of human colorectal carcinoma in culture transduced with cytosine deaminase gene Clin Cancer Res 1996 2: 53–57
Goodman JC, Trask TW, Chen S-H . Adenoviral-mediated thymidine kinase gene transfer into the primate brain followed by systemic ganciclovir: pathologic, radiologic, and molecular studies Hum Gene Ther 1996 7: 1241–1250
Smith JG, Raper SE, Wheeldon EB . Intracranial administration of adenovirus-expressing HSV-TK in combination with ganciclovir produces a dose-dependent, self-limiting inflammatory response Hum Gene Ther 1997 8: 943–9564
Acknowledgements
We thank Hideki Wakimoto, Masako Arao, and Mayumi Konishi for their technical assistance and Judy Yamamoto for her English editorial assistance. This study was supported by Grants-in-Aid for Scientific Research from the Japan Ministry of Education, Science, Sports and Culture (nos. 14370433 and 14571312).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kambara, H., Tamiya, T., Ono, Y. et al. Combined radiation and gene therapy for brain tumors with adenovirus-mediated transfer of cytosine deaminase and uracil phosphoribosyltransferase genes. Cancer Gene Ther 9, 840–845 (2002). https://doi.org/10.1038/sj.cgt.7700506
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.cgt.7700506
Keywords
This article is cited by
-
Recent progress in the research of suicide gene therapy for malignant glioma
Neurosurgical Review (2021)
-
Isocytosine deaminase Vcz as a novel tool for the prodrug cancer therapy
BMC Cancer (2019)
-
Emerging Implications of Nonmammalian Cytosine Deaminases on Cancer Therapeutics
Applied Biochemistry and Biotechnology (2012)
-
Escherichia coli nitroreductase plus CB1954 enhances the effect of radiotherapy in vitro and in vivo
Gene Therapy (2008)
-
Modified vaccinia virus Ankara as a vector for suicide gene therapy
Cancer Gene Therapy (2008)